BACILLUS COAGULANS

OTHER NAME(S):

B. Coagulans, Bacillus Bacteria, Bacillus Probiotics, Bactéries Bacilles, Bactéries à Gram Positif Sporogènes, Bactérie Gram Positive en Forme de Bâtonnet, Gram Positive Spore-Forming Rod, L. Sporogenes, Lactobacillus Sporogenes, Lactobacillus Sporogènes, Probiotic, Probiotique, Spore-Forming Lactobacillus.<br/><br/>

Overview

Overview Information

Bacillus coagulans is a type of bacteria. It is used similarly to lactobacillus and other probiotics as "beneficial" bacteria.

People take Bacillus coagulans for diarrhea, including infectious types such as rotaviral diarrhea, traveler's diarrhea, and diarrhea caused by antibiotics. Bacillus coagulans is also used for general digestion problems, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gas (flatulence), a bowel disorder called Clostridium difficile colitis, and excessive growth of "bad" bacteria in the intestine. It is also used in people with liver cirrhosis, for an infection due to the ulcer-causing bacterium Helicobacter pylori, for rheumatoid arthritis, and for HIV/AIDS.

Some people use Bacillus coagulans to prevent respiratory infections and ramp up the immune system. It is also used to prevent cancer or the formation of cancer-causing agents. There is also some interest in using it as an additive to vaccines to improve their effectiveness.

Bacillus coagulans produces lactic acid and is often misclassified as lactobacillus. In fact, some commercial products containing Bacillus coagulans are marketed as Lactobacillus sporogenes. Unlike lactic acid bacteria such as lactobacillus or bifidobacteria, Bacillus coagulans forms spores. Spores are an important factor in telling Bacillus coagulans apart from other lactic acid bacteria.

How does it work?

There is not enough information to know how Bacillus coagulans might work for medical purposes. Some research shows that Bacillus coagulans might increase immune system function and decrease harmful bacteria.

Uses

Uses & Effectiveness?

Possibly Effective for

  • Irritable bowel syndrome (IBS). Clinical research shows that taking Bacillus coagulans daily for 56-90 days improves quality of life and decreases bloating, vomiting, abdominal pain, and the number of bowel movements in people with diarrhea-predominant IBS. Other clinical research shows that taking a specific combination product (Colinox, DMG Italia SRL) containing Bacillus coagulans and simethicone three times daily for 4 weeks improves bloating and discomfort in people with IBS.

Insufficient Evidence for

  • Liver scarring (cirrhosis). People with liver cirrhosis are more likely to develop an infection called spontaneous bacterial peritonitis, or SBP. Early research shows that taking a combination probiotic containing Bacillus coagulans and other bacteria three times daily, along with the drug norfloxacin, does not decrease a person's risk of developing SBP.
  • Diarrhea. Early research in babies 6-24 months of age with diarrhea shows that taking Bacillus coagulans twice daily for up to 5 days does not decrease the duration, frequency, or quantity of diarrhea.
  • Diarrhea in children caused by a certain virus (rotavirus). Early research in newborn babies shows that taking Bacillus coagulans daily for one year decreases the child's risk of developing rotavirus diarrhea.
  • Gas (flatulence). Early evidence in people who have gas after eating shows that taking a specific combination supplement containing Bacillus coagulans and a blend of enzymes daily for 4 weeks does not improve bloating or gas .
  • Growth of bacteria in the intestine. Early evidence shows that using a specific probiotic product (Lactol, Bioplus Life Sciences Pvt. Ltd.) containing Bacillus coagulans and fructo-oligosaccharides daily for 15 days of every month for 6 months might modestly decrease stomach pain and gas in people with potentially harmful bacteria in the intestine.
  • Rheumatoid arthritis (RA). Early research shows that taking Bacillus coagulans daily for 60 days in addition to normal treatment can reduce pain, but does not reduce the number of painful or swollen joints in people with RA. Bacillus coagulans also does not improve the ability to perform activities of daily living in people with RA.
  • Serious infection of the intestines (necrotizing enterocolitis). Babies that are born very early or with a very low weight are at a higher risk of developing a serious infection in the intestines called necrotizing enterocolitis. Early research in these babies shows that taking Bacillus coagulans daily until leaving the hospital does not prevent necrotizing enterocolitis or death. However, taking Bacillus coagulans does increase the number of babies that are able to tolerate food.
  • Cancer prevention.
  • Clostridium difficile colitis.
  • Digestion problems.
  • Helicobacter pylori infection.
  • Immune system strengthening.
  • Inflammatory bowel disease (IBD, Crohn's disease, ulcerative colitis).
  • Respiratory infections.
More evidence is needed to rate Bacillus coagulans for these uses.
Side Effects

Side Effects & Safety

Bacillus coagulans is POSSIBLY SAFE when taken by mouth. Some research has shown that Bacillus coagulans can be safely used by adults for up to 6 months.

Bacillus coagulans is POSSIBLY SAFE when taken by mouth in infants and children. Some research has shown that Bacillus coagulans can be safely used by infants for up to one year.

Special Precautions & Warnings:

Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking Bacillus coagulans if you are pregnant or breast feeding. Stay on the safe side and avoid use.
Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Antibiotic drugs interacts with BACILLUS COAGULANS

    Antibiotics are used to reduce harmful bacteria in the body. Antibiotics can also reduce other bacteria in the body. Taking antibiotics along with Bacillus coagulans might reduce the potential benefits of Bacillus coagulans. To avoid this potential interaction take Bacillus coagulans products at least 2 hours before or after antibiotics.

  • Medications that decrease the immune system (Immunosuppressants) interacts with BACILLUS COAGULANS

    Bacillus coagulans might increase the immune system. Taking Bacillus coagulans along with medications that decrease the immune system might decrease the effectiveness of medications that decrease the immune system.<br /> Some medications that decrease the immune system include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.

Dosing

Dosing

The following doses have been studied in scientific research:

ADULTS

BY MOUTH:

  • For irritable bowel syndrome (IBS): Bacillus coagulans (Lactospore, Sabinsa Corporation) 2 billion colony forming units (CFUs) daily for 90 days. Bacillus coagulans (GanedenBC30, Ganeden Biotech Inc.) 300 million to 2 billion CFUs daily for 8 weeks. Also, a specific combination product (Colinox, DMG Italia SRL) containing Bacillus coagulans and simethicone has been used after each meal three times daily for 4 weeks.

View References

REFERENCES:

  • Chandra RK. Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhea in infants. A prospective placebo-controlled double-blind study. Nutr Res 2002;22:65-9.
  • Czaczyk K, Tojanowska K, Mueller A. Antifungal activity of Bacillus coagulans against Fusarium sp. Acta Microbiol Pol 2002;51:275-83. View abstract.
  • De Vecchi E, Drago L. Lactobacillus sporogenes or Bacillus coagulans: misidentification or mislabeling? Int J Probiotics Prebiotics 2006;1(1):3-10.
  • Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol 2009;31(10):655-9. View abstract.
  • Donskey CJ, Hoyen CK, Das SM, et al. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol 2001;33:84-8. View abstract.
  • Duc LH, Hong HA, Barbosa TM, et al. Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 2004;70:2161-71. View abstract.
  • Dutta P, Mitra U, Dutta S, et al. Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as a probiotic in clinical practice, on acute watery diarrhea in children. Trop Med Int Health 2011;16(5):555-61. View abstract.
  • Endres JR, Clewell A, Jade KA, et al. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 2009;47(6):1231-8. View abstract.
  • Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med 2009;121(2):119-24. View abstract.
  • Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bacteriocin-like inhibitory subtances produced by Bacillus coagulans I4. J Appl Microbiol 1998;85:42-50. View abstract.
  • Jurenka JS. Bacillus coagulans: Monograph. Altern Med Rev 2012;17(1):76-81. View abstract.
  • Kalman DS, Schwartz HI, Alvarez P, et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 2009;9:85. View abstract.
  • Khalighi AR, Khalighi MR, Behdani R, et al. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study. Indian J Med Res. 2014 N ov;140(5):604-8. View abstract.
  • Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J 2016;15:21. View abstract.
  • Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 2010;10:1. View abstract.
  • McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 1993;6:251-64. View abstract.
  • Pande C, Kumar A, Sarin SK. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial. Eur J Gastroenterol Hepatol 2012;24(7):831-9. View abstract.
  • Probiotics for antibiotic-associated diarrhea. Pharmacist's Letter / Prescriber's Letter 2000;16(1):160103.
  • Reid G, Bruce AW, Cook RL, et al. Effect on urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis 1990;22:43-7. View abstract.
  • Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J Appl Microbiol 2009;106(4):1370-7. View abstract.
  • Sari FN, Dizdar EA, Oguz S, et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011;65(4):434-9. View abstract.
  • Urgesi R, Casale C, Pistelli R, et al. A randomized double-blind placebo-controlled trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox) in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2014;18(9):1344-53. View abstract.
  • Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol 1996;62:1958-63. View abstract.
  • Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retroviruses 2014;30(10):988-95. View abstract.

Vitamins Survey

Have you ever purchased BACILLUS COAGULANS?

Did you or will you purchase this product in-store or online?

Where did you or where do you plan to purchase this product?

Where did you or where do you plan to purchase this product?

What factors influenced or will influence your purchase? (check all that apply)

Vitamins Survey

Where did you or where do you plan to purchase this product?

Do you buy vitamins online or instore?

What factors are most important to you? (check all that apply)

This survey is being conducted by the WebMD marketing sciences department.Read More

More Resources for BACILLUS COAGULANS

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.